[1]
|
张绍丹, 卿国平, 王怀洲, 等. 神经影像学技术在认识青光眼相关的中枢损伤性疾病过程中的作用[J]. 中华眼科医学杂志: 电子版, 2016, 6(2): 93-96.
|
[2]
|
Romero-Aroca, P., Montero-Jaime, M., Intriago, B., et al. (2012) 18FDG-PET/CT Assessing the Absence of Cell Viability and Excluding Metastatic Disease in a Case of Necrotic Choroidal Melanoma. European Journal of Ophthalmology, 22, 288. https://doi.org/10.5301/ejo.5000016
|
[3]
|
Dietemann, S., Noblet, V., et al. (2015) FDG PET Findings of the Brain in Sudden Blindness Caused by Bilateral Central Retinal Artery Occlusion Revealing Giant Cell Arteritis. Clinical Nuclear Medicine, 40, 45-46.
https://doi.org/10.1097/RLU.0000000000000598
|
[4]
|
Deshka, D., Christoph, D., Juergen, H., et al. (2011) The Use of Positron Emission Tomography/CT in the Diagnosis of Tuberculosis-Associated Uveitis. The British Journal of Ophthalmology, 95, 1290-1294.
https://doi.org/10.1136/bjo.2010.182659
|
[5]
|
董志章, 李娟, 孙雪荣, 等. TgAPPswePS1转基因鼠视网膜的功能损伤和Aβ斑块沉积[J]. 中华眼视光学与视觉科学杂志, 2018, 20(1): 46-52.
|
[6]
|
Tsuruma, K., Tanaka, Y., Shimazawa, M., et al. (2010) Induction of Amyloid Precursor Protein by the Neurotoxic Peptide, Amyloid-Beta 25-35, Causes Retinal Ganglion Cell Death. Journal of Neurochemistry, 113, 1545-1554.
https://doi.org/10.1111/j.1471-4159.2010.06724.x
|
[7]
|
Prakasam, A., Muthuswamy, A., Ablonczy, Z., et al. (2010) Differential Accumulation of Secreted AβPP Metabolites in Ocular Fluids. Journal of Alzheimer’s Disease, 20, 1243-1253. https://doi.org/10.3233/JAD-2010-100210
|
[8]
|
卢艳, 李臻, 吴越, 张健, 等. 116例正常人房水中阿尔茨海默病生物标志物与年龄相关性研究[J]. 首都医科大学学报, 2017, 38(3): 461-464.
|
[9]
|
周金子, 鲁建华, 张文芳. 青光眼患者房水中β淀粉样蛋白的检测[J]. 临床眼科杂志, 2005, 13(3): 202-204.
|
[10]
|
Rabinovici, G.D., Gatsonis, C., Apgar, C., et al. (2019) Association of Amyloid Positron Emission Tomography with Subsequent Change in Clinical Management among Medicare Beneficiaries with Mild Cognitive Impairment or Dementia. JAMA, 321, 1286-1294. https://doi.org/10.1001/jama.2019.2000
|
[11]
|
Ciarmiello, A., Tartaglione, A., Giovannini, E., et al. (2019) Amyloid Burden Identifies Neuropsychological Phenotypes at Increased Risk of Progression to Alzheimer’s Disease in Mild Cognitive Impairment Patients. European Journal of Nuclear Medicine and Molecular Imaging, 46, 288-296. https://doi.org/10.1007/s00259-018-4149-2
|
[12]
|
Hatashita, S., Yamasaki, H., Suzuki, Y., et al. (2014) 18F-Flutemetamol Amyloid-Beta PET Imaging Compared with 11C-PIB across the Spectrum of Alzheimer’s Disease. European Journal of Nuclear Medicine & Molecular Imaging, 41, 290-300. https://doi.org/10.1007/s00259-013-2564-y
|
[13]
|
任树华, 黄琪, 胡静超, 等. 18F-AV45 PET显像在轻微认知下降和轻度认知障碍患者中的应用[J]. 中华核医学与分子影像杂志, 2020, 40(4): 196-200.
|
[14]
|
张晨鹏, 王成, 辛玫, 等. 18F-AV45 PET/CT显像视觉分析及SUVR对不同认知障碍患者的辅助诊断价值[J]. 中华核医学与分子影像杂志, 2020, 40(4): 201-206.
|
[15]
|
Jia, L., Quan, M., Fu, Y., et al. (2020) Dementia in China: Epidemiology, Clinical Management, and Research Advances. The Lancet Neurology, 19, 81-92. https://doi.org/10.1016/S1474-4422(19)30290-X
|
[16]
|
Lin, K.J., Haiao, I.T., Hsu, J.L., et al. (2016) Imaging Characteristic of Dual-Phase 18F-Florbetapir (AV-45/Amyvid) PET for the Concomitant Detection of Perfusion Deficits and Beta-Amyloid Deposition in Alzheimer’s Disease and Mild Cognitive Impairment. European Journal of Nuclear Medicine and Molecular Imaging, 43, 1304-1314.
https://doi.org/10.1007/s00259-016-3359-8
|
[17]
|
D’Estanque, E., Chambert, B., Moranne, O., et al. (2016) 18F-Florbetaben: A New Tool for Amyloidosis Staging. Clinical Nuclear Medicine, 42, 50. https://doi.org/10.1097/RLU.0000000000001434
|
[18]
|
Neiberg, M.N. (2009) Alzheimer’s Disease and the Eye. Eye Care Review.
|
[19]
|
Tamura, H., Kawakami, H., Kanamoto, T., et al. (2006) High Frequency of Open-Angle Glaucoma in Japanese Patients with Alzheimer’s Disease. Journal of the Neurological Sciences, 246, 79-83.
https://doi.org/10.1016/j.jns.2006.02.009
|
[20]
|
Sivak, J.M. (2013) The Aging Eye: Common Degenerative Mechanisms between the Alzheimer’s Brain and Retinal Disease. Investigative Ophthalmology & Visual Science, 54, 871-880. https://doi.org/10.1167/iovs.12-10827
|
[21]
|
Sevigny, J., Chiao, P., Bussière, T., et al. (2016) The Antibody Aducanumab Reduces Aβ Plaques in Alzheimer’s Disease. Nature, 537, 50-56. https://doi.org/10.1038/nature19323
|
[22]
|
López-de-Eguileta, A., Lage, C., López-García, S., et al. (2019) Ganglion Cell Layer Thinning in Prodromal Alzheimer’s Disease Defined by Amyloid PET. Alzheimer’s Dement, 5, 570-578. https://doi.org/10.1016/j.trci.2019.08.008
|
[23]
|
Shimazawa, M., Ito, Y., Inokuchi, Y., et al. (2012) An Alteration in the Lateral Geniculate Nucleus of Experimental Glaucoma Monkeys: In Vivo Positron Emission Tomography Imaging of Glial Activation. PLoS ONE, 7, e30526.
https://doi.org/10.1371/journal.pone.0030526
|